Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: A patient-level meta-analysis
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Summary: Residual venous obstruction (RVO) could improve the stratification of the risk of recurrence after unprovoked deep vein thrombosis (DVT), but results from clinical studies and study-level meta-analyses are conflicting. It was the objective of this analysis to determine if RVO is a valid predictor of recurrent venous thromboembolism (VTE) in patients with a first unprovoked DVT who had received at least three months of anticoagulant therapy. Individual patient data were obtained from the datasets of original studies, after a systematic search of electronic databases (Medline, Embase, Cochrane Library), supplemented by manual reviewing of the reference lists and contacting content experts. A multivariate, shared-frailty Cox model was used to calculate hazard ratios (HRs) for recurrent VTE, including, as covariates: RVO; age; sex; anticoagulation duration before RVO assessment; and anticoagulation continuation after RVO assessment. A total of 2,527 patients from 10 prospective studies were included. RVO was found in 1,380 patients (55.1%) after a median of six months from a first unprovoked DVT. Recurrent VTE occurred in 399 patients (15.8%) during a median follow-up of 23.3 months. After multivariate Cox analysis, RVO was independently associated with recurrent VTE (HR = 1.32, 95% confidence interval [CI]: 1.06–1.65). The association was stronger if RVO was detected early, i.e. at three months after DVT (HR = 2.17; 95% CI: 1.11–4.25), but non-significant if detected later, i.e. >6 months (HR = 1.19; 95% CI: 0.87–1.61). In conclusion, after a first unprovoked DVT, RVO is a weak overall predictor of recurrent VTE. The association is stronger if RVO is detected at an earlier time (3 months) after thrombosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an individual patient meta-analysis of observational studies and 1 RCT (n 5 2527) 300 showed an independent association of residual vein thrombosis and recurrent VTE (HR, 1.32; 95% CI, 1.06-1.65).”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [300]
Citations
Cites
(2014) · Medical Entomology and Zoology · Cited by 17,633
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396 · cited 2×
“The selection of The risk of bias in RCTs was evaluated in accordance with the assessment provided by the Cochrane Collaboration (22).”
MethodHeit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352 · cited 1×
“with cancer) in whom indefinite anticoagulation is recommended (4, 19), and patients with isolated distal (calf) DVT in whom the need for anticoagulation is questionable (4, 20).”
BackgroundKearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072 · cited 1×
“We excluded studies that had been included in previous meta-analyses (16, 17) for the following reasons: patients had >1 previous unprovoked VTE (31); timing of RVO assessment was not specified (32); the study population consisted of only patients with provoked DVT (33, 34); and a definition of RVO was not provided (3…”
MethodSelf-citationPrandoni, P., Noventa, F., Ghirarduzzi, A., Pengo, V., Bernardi, E., Pesavento, R., Iotti, M., Tormene, D., Simioni, P., & Pagnan, A. (2007) · Haematologica · doi:10.3324/haematol.10516 · Cited by 776
Self-citationKearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Self-citationBates, S. M., Jaeschke, R., Stevens, S. M., Goodacre, S., Wells, P. S., Stevenson, M. D., Kearon, C., Schunemann, H. J., Crowther, M., Pauker, S. G., et al. (2012) · Chest · doi:10.1378/chest.11-2299 · Cited by 686
Rodger, M. A., Kahn, S. R., Wells, P. S., Anderson, D. A., Chagnon, I., Le Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080493 · Cited by 581
Self-citationResidual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism
Prandoni, P., Lensing, A. W. A., Prins, M. H., Bernardi, E., Marchiori, A., Bagatella, P., Frulla, M., Mosena, L., Tormene, D., Piccioli, A., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00008 · Cited by 547
Self-citationEichinger, S., Heinze, G., Jandeck, L. M., & Kyrle, P. A. (2010) · Circulation · doi:10.1161/circulationaha.109.925214 · Cited by 510 · cited 1×
“Fifth, we acknowledge that the prognostic significance of RVO should be addressed in the context of other putative predictors of recurrent VTE (38-40).”
BackgroundTOSETTO, A., IORIO, A., MARCUCCI, M., BAGLIN, T., CUSHMAN, M., EICHINGER, S., PALARETI, G., POLI, D., TAIT, R. C., & DOUKETIS, J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04735.x · Cited by 443 · cited 1×
“Fifth, we acknowledge that the prognostic significance of RVO should be addressed in the context of other putative predictors of recurrent VTE (38-40).”
BackgroundSelf-citationIorio, A., Kearon, C., Filippucci, E., Marcucci, M., Macura, A., Pengo, V., Siragusa, S., & Palareti, G. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.367 · Cited by 385 · cited 1×
“surgery) because such patients are at low risk for recurrent VTE and >3 months of anticoagulation usually is not recommended (4, 18), patients at high risk for recurrence (e.”
BackgroundSelf-citationA simple ultrasound approach for detection of recurrent proximal-vein thrombosis.
Prandoni, P., Cogo, A., Bernardi, E., Villalta, S., Polistena, P., Simioni, P., Noventa, F., Benedetti, L., & Girolami, A. (1993) · Circulation · doi:10.1161/01.cir.88.4.1730 · Cited by 303 · cited 4×
“study-level data but the datasets of the three oldest studies (1, 23, 24) were not available in electronic format, precluding their inclusion into the pooled database and leaving 10 studies in this analysis (12-15, 25-30).”
BackgroundMethodInfluentialSelf-citationThe post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease
STAIN, M., SCHÖNAUER, V., MINAR, E., BIALONCZYK, C., HIRSCHL, M., WELTERMANN, A., KYRLE, P. A., & EICHINGER, S. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01648.x · Cited by 301 · cited 1×
“While factors such as patient sex, D-dimer levels and post-thrombotic signs and symptoms may inform decisions about the duration of anticoagulation (7-9), RVO may be a pivotal factor in clinicians’ decision-making.”
BackgroundRisk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R. C., & Iorio, A. (2011) · BMJ · doi:10.1136/bmj.d813 · Cited by 278 · cited 1×
“While factors such as patient sex, D-dimer levels and post-thrombotic signs and symptoms may inform decisions about the duration of anticoagulation (7-9), RVO may be a pivotal factor in clinicians’ decision-making.”
BackgroundSelf-citationRighini, M., Sanchez, O., Roy, P.-M., Baba-Ahmed, M., Perrier, A., Bounameaux, H., & Le Gal, G. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-03-0158 · Cited by 236
Self-citationPrandoni, P., Prins, M. H., Lensing, A. W. A., Ghirarduzzi, A., Ageno, W., Imberti, D., Scannapieco, G., Ambrosio, G. B., Pesavento, R., Cuppini, S., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00003 · Cited by 232
Self-citationSiragusa, S., Malato, A., Anastasio, R., Cigna, V., Milio, G., Amato, C., Bellisi, M., Attanzio, M. T., Cormaci, O., Pellegrino, M., et al. (2008) · Blood · doi:10.1182/blood-2008-01-131656 · Cited by 196
Self-citationPiovella, F., Crippa, L., Barone, M., D’Angelo, S. V., Serafini, S., Galli, L., Beltrametti, C., & D’Angelo, A. (2002) · PubMed · Cited by 189
Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cushman, M., Eichinger, S., Palareti, G., Poli, D., Tait, R. C., & Iorio, A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-8-201010190-00009 · Cited by 175 · cited 1×
“While factors such as patient sex, D-dimer levels and post-thrombotic signs and symptoms may inform decisions about the duration of anticoagulation (7-9), RVO may be a pivotal factor in clinicians’ decision-making.”
BackgroundSelf-citationClinical relevance of distal deep vein thrombosis. Review of literature data.
Righini, M., Paris, S., Gal, G. L., Laroche, J.-P., Perrier, A., & Bounameaux, H. (2006) · PubMed · Cited by 169
Self-citationCARRIER, M., RODGER, M. A., WELLS, P. S., RIGHINI, M., & LE GAL, G. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04254.x · Cited by 159 · cited 4×
“(16), which found a non-significant association between RVO and recurrent VTE (odds ratio [OR] = 1.”
BackgroundMethodResultInfluentialSelf-citationKearon, C., Ginsberg, J. S., Anderson, D. R., Kovacs, M. J., Wells, P. S., Julian, J. A., MacKinnon, B., Demers, C., Douketis, J. D., Turpie, A. G. G., et al. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2004.00698.x · Cited by 147 · cited 1×
“We excluded studies that had been included in previous meta-analyses (16, 17) for the following reasons: patients had >1 previous unprovoked VTE (31); timing of RVO assessment was not specified (32); the study population consisted of only patients with provoked DVT (33, 34); and a definition of RVO was not provided (3…”
MethodSelf-citationClinical relevance of distal deep vein thrombosis: Review of literature data
Paris, S., Le Gal, G., Laroche, J.-P., Perrier, A., Bounameaux, H., & Righini, M. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-08-0588 · Cited by 144
Self-citationPost‐treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality
YOUNG, L., Ockelford, P., Milne, D. G., Rolfe‐Vyson, V., MCKELVIE, S., & HARPER, P. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02120.x · Cited by 126 · cited 4×
“study-level data but the datasets of the three oldest studies (1, 23, 24) were not available in electronic format, precluding their inclusion into the pooled database and leaving 10 studies in this analysis (12-15, 25-30).”
BackgroundMethodInfluentialSelf-citationLegnani, C., Cini, M., Guazzaloca, G., Palareti, G., & Cosmi, B. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-02-0095 · Cited by 104
Self-citationTan, M., Mos, I. C. M., Klok, F. A., & Huisman, M. V. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08578.x · Cited by 104
Heijboer, H., Jongbloets, L. M. M., Buller, H. R., Lensing, A. W. A., & ten Cate, J. W. (1992) · Acta Radiologica · doi:10.1080/02841859209173182 · Cited by 93
Hull, R. D., Marder, V. J., Mah, A. F., Biel, R. K., & Brant, R. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.025 · Cited by 88
Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis
Meissner, M. H., Zierler, B. K., Bergelin, R. O., Chandler, W. L., & Strandness, D. E. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.121066 · Cited by 87 · cited 2×
“In support of this contention, previous data indicate that the degree of recanalisation after DVT is directly associated with t-PA activity and inversely related to t-PA antigen and PAI-1 levels, when measured at the time of DVT diagnosis (11).”
BackgroundResultLinkins, L., Stretton, R., Probyn, L. J., & Kearon, C. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.02.011 · Cited by 79 · cited 1×
“Second, there is the potential that inter-observer variability of RVO measurements may affect the reliability of our findings (36, 37).”
BackgroundValidation of a diagnostic approach to exclude recurrent venous thromboembolism
Gal, G. L., Kovacs, M. J., Carrier, M., Do, K., Kahn, S. R., Wells, P. S., Anderson, D. R., Chagnon, I., Solymoss, S., Crowther, M. A., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03324.x · Cited by 70 · cited 1×
“During this assessment, many experts suggest that clinicians also repeat leg venous ultrasound imaging so that if patients develop suspected recurrent DVT in future this, more recent, imaging helps to distinguish old from new DVT (1-3).”
BackgroundSelf-citationSiragusa, S. M., Malato, A., Saccullo, G., Iorio, A., Ianni, M. D., Caracciolo, C., Coco, L. L., Raso, S., Santoro, M., Guarneri, F. P., et al. (2011) · American Journal of Hematology · doi:10.1002/ajh.22156 · Cited by 67 · cited 5×
“study-level data but the datasets of the three oldest studies (1, 23, 24) were not available in electronic format, precluding their inclusion into the pooled database and leaving 10 studies in this analysis (12-15, 25-30).”
BackgroundMethodInfluentialSelf-citationCosmi, B., Legnani, C., Iorio, A., Pengo, V., Ghirarduzzi, A., Testa, S., Poli, D., Tripodi, A., & Palareti, G. (2010) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2009.11.022 · Cited by 57
Self-citationPoli, D., Antonucci, E., Ciuti, G., Abbate, R., & Prisco, D. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02900.x · Cited by 57 · cited 3×
“study-level data but the datasets of the three oldest studies (1, 23, 24) were not available in electronic format, precluding their inclusion into the pooled database and leaving 10 studies in this analysis (12-15, 25-30).”
MethodResultSelf-citationHamadah, A., Alwasaidi, T., Gal, G. L., Carrier, M., Wells, P. S., Scarvelis, D., Gonsalves, C., Forgie, M., Kovacs, M. J., & Rodger, M. A. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04533.x · Cited by 56 · cited 1×
“During this assessment, many experts suggest that clinicians also repeat leg venous ultrasound imaging so that if patients develop suspected recurrent DVT in future this, more recent, imaging helps to distinguish old from new DVT (1-3).”
BackgroundSelf-citationAziz, F., & Comerota, A. J. (2012) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2012.04.016 · Cited by 54 · cited 1×
“Moreover, this finding is consistent with other studies which found a significant correlation between early thrombus regression (measured by venography) and recurrent VTE (41-43).”
ResultGal, G. L., Carrier, M., Kovacs, M. J., Betancourt, M. T., Kahn, S. R., Wells, P. S., Anderson, D. R., Chagnon, I., Solymoss, S., CROWTHER, M., et al. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04240.x · Cited by 52 · cited 7×
“study-level data but the datasets of the three oldest studies (1, 23, 24) were not available in electronic format, precluding their inclusion into the pooled database and leaving 10 studies in this analysis (12-15, 25-30).”
BackgroundMethodResultInfluentialSelf-citationCosmi, B., Legnani, C., Cini, M., Guazzaloca, G., & Palareti, G. (2005) · PubMed · Cited by 47
Self-citationHeijboer, H., Jongbloets, L. M. M., Buller, H. R., Lensing, A. W. A., & ten Cate, J. W. (1992) · Acta Radiologica · doi:10.1177/028418519203300403 · Cited by 47 · cited 3×
“study-level data but the datasets of the three oldest studies (1, 23, 24) were not available in electronic format, precluding their inclusion into the pooled database and leaving 10 studies in this analysis (12-15, 25-30).”
BackgroundMethodGómez‐Outes, A., Lecumberri, R., Lafuente‐Guijosa, A., Martínez, J., Carrasco, P., & Rocha, E. A. V. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00862.x · Cited by 32
Clinical predictors of recurrent venous thromboembolism: A single institute experience in Korea
Kim, T. M., Kim, J. S., Han, S., Hong, Y. S., Kim, I., Ha, J., Kim, S. J., Chung, J. W., Park, J. H., Lee, D., et al. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.05.009 · Cited by 32 · cited 1×
“We excluded studies that had been included in previous meta-analyses (16, 17) for the following reasons: patients had >1 previous unprovoked VTE (31); timing of RVO assessment was not specified (32); the study population consisted of only patients with provoked DVT (33, 34); and a definition of RVO was not provided (3…”
MethodTan, M., Bornais, C., & Rodger, M. A. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04827.x · Cited by 24 · cited 1×
“Second, there is the potential that inter-observer variability of RVO measurements may affect the reliability of our findings (36, 37).”
BackgroundSelf-citationKearon, C. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0573-x · Cited by 13 · cited 2×
“As shown in ▶ Figure 2, there were 4,069 patients initially considered of which 488 were excluded because of unavailable electronic datasets and 1,054 patients were excluded for the following reasons: provoked index DVT (n = 692); anticoagulation duration based on persistent RVO (n = 270); isolated pulmonary embolism…”
BackgroundAgeno, W., Steidl, L., Piantanida, E., Dentali, F., Mera, V., Squizzato, A., Marchesi, C., & Venco, A. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(03)00063-x · Cited by 11 · cited 2×
“study-level data but the datasets of the three oldest studies (1, 23, 24) were not available in electronic format, precluding their inclusion into the pooled database and leaving 10 studies in this analysis (12-15, 25-30).”
MethodSelf-citationWhich patients with unprovoked VTE should receive extended anticoagulation? the minority
Donadini, M. P., & Ageno, W. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0565-x · Cited by 5 · cited 1×
“The prognostic significance of RVO pertains most for patients with unprovoked (or idiopathic) DVT, in whom the duration of anticoagulation is uncertain (5, 6).”
BackgroundSelf-citation
Cited by
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
Self-citationKakkos, S. K., Gohel, M., Baekgaard, N., Bauersachs, R., Bellmunt-Montoya, S., Black, S. A., ten Cate-Hoek, A. J., Elalamy, I., Enzmann, F. K., Geroulakos, G., et al. (2021) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2020.09.023 · Cited by 743
Self-citationGuidance for the treatment of deep vein thrombosis and pulmonary embolism
Streiff, M. B., Agnelli, G., Connors, J. M., Crowther, M., Eichinger, S., Lopes, R., McBane, R. D., Moll, S., & Ansell, J. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1317-0 · Cited by 344
Guidance for the evaluation and treatment of hereditary and acquired thrombophilia
Stevens, S. M., Woller, S. C., Bauer, K. A., Kasthuri, R., Cushman, M., Streiff, M., Lim, W., & Douketis, J. D. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1316-1 · Cited by 345
Self-citationNeedleman, L., Cronan, J. J., Lilly, M. P., Merli, G. J., Adhikari, S., Hertzberg, B. S., DeJong, M. R., Streiff, M. B., & Meissner, M. H. (2018) · Circulation · doi:10.1161/circulationaha.117.030687 · Cited by 322
Metadata
- Authors
- Ageno, W., Antonucci, E., Cosmi, B., Kovacs, M. J., Gal, G. L., Ockelford, P., Poli, D., Prandoni, P., Rodger, M., Saccullo, G., Siragusa, S., Young, L., Bonzini, M., Caprioli, M., Dentali, F., Iorio, A., Douketis, J. D., & Donadini, M. P.
- Affiliations
- University of Insubria (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Western University (CA)
- Centre Hospitalier Régional Universitaire de Brest (FR)
- Auckland City Hospital (NZ)
- University of Padua (IT)
- University of Ottawa (CA)
- University of Palermo (IT)
- University of Auckland (NZ)
- McMaster University (CA)
- Corresponding author
- Donadini, Marco P.
- ORCID
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2014
- Volume
- 111
- Issue
- 01
- Pages
- 172-179
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1830075536
- Cited by
- 111
- References
- 47
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 7 · 2023: 13 · 2022: 7 · 2021: 2 · 2020: 8 · 2019: 9 · 2018: 14 · 2017: 14 · 2016: 15 · 2015: 8 · 2014: 4
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
- Keywords
- recurrent venous thromboembolism, anticoagulation, prognostic factors, individual patient data meta-analysis
- MeSH terms
- Aged, Anticoagulants, Female, Humans, Male, Middle Aged, Recurrence, Sensitivity and Specificity, Thrombosis, Ultrasonography, Reproducibility of Results, Cohort Studies, Multivariate Analysis, Proportional Hazards Models, Randomized Controlled Trials as Topic, Thrombectomy, Venous Thrombosis, Venous Thromboembolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.